{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T10:29:33Z","timestamp":1773829773063,"version":"3.50.1"},"reference-count":15,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,23]],"date-time":"2021-11-23T00:00:00Z","timestamp":1637625600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gaceta Sanitaria"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.gaceta.2021.11.003","type":"journal-article","created":{"date-parts":[[2021,11,26]],"date-time":"2021-11-26T00:13:51Z","timestamp":1637885631000},"page":"484-487","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Efectividad de la vacuna BNT162b2 para prevenir la COVID-19 en personal sanitario"],"prefix":"10.1016","volume":"36","author":[{"given":"Pablo","family":"Chico-S\u00e1nchez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"Gras-Valent\u00ed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natividad","family":"Algado-Sell\u00e9s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esperanza","family":"Merino-Lucas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Carlos","family":"Rodr\u00edguez-D\u00edaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Ronda-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"S\u00e1nchez-Pay\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gaceta.2021.11.003_bib0080","unstructured":"European Centre for Disease Prevention and Control. Guidelines for non-pharmaceutical interventions to reduce the impact of COVID-19 in the EU\/EEA and the UK. 24 September 2020. ECDC: Stockholm; 2020. (Consultado el 20\/6\/2021.) Disponible en: https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/covid-19-guidelines-non-pharmaceutical-interventions-september-2020.pdf."},{"key":"10.1016\/j.gaceta.2021.11.003_bib0085","unstructured":"Estrategia de vacunaci\u00f3n frente a COVID-19 en Espa\u00f1a. Grupo de Trabajo T\u00e9cnico de Vacunaci\u00f3n COVID-19 de la Ponencia de Programa y Registro de Vacunaciones. Actualizaci\u00f3n 8. Ministerio de Sanidad, Gobierno de Espa\u00f1a; 2021. (Consultado el 24\/6\/2021.) Disponible en: https:\/\/www.mscbs.gob.es\/profesionales\/saludPublica\/prevPromocion\/vacunaciones\/covid19\/docs\/COVID-19_Actualizacion8_EstrategiaVacunacion.pdf."},{"key":"10.1016\/j.gaceta.2021.11.003_bib0090","unstructured":"European Medicines Agency (EMA). Comirnaty COVID-19 mRNA vaccine (nucleoside-modified). EMA: Amsterdan, Netherlands; 2021. (Consultado el 27\/6\/2021.) Disponible en: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/comirnaty."},{"key":"10.1016\/j.gaceta.2021.11.003_bib0095","unstructured":"Ministerio de Sanidad. GIV COVID-19. Informe de actividad de la vacunaci\u00f3n, 2021. (Consultado el 28\/6\/2021.) Disponible en: https:\/\/www.mscbs.gob.es\/profesionales\/saludPublica\/ccayes\/alertasActual\/nCov\/documentos\/Informe_GIV_comunicacion_20210927.pdf."},{"key":"10.1016\/j.gaceta.2021.11.003_bib0100","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med."},{"key":"10.1016\/j.gaceta.2021.11.003_bib0105","unstructured":"European Centre for Disease Prevention and Control. Enhanced post-marketing monitoring of COVID-19 vaccines in Europe. ECDC: Stockholm; 2021. (Consultado el 20\/6\/2021.) Disponible en: https:\/\/www.ecdc.europa.eu\/en\/news-events\/ema-and-ecdc-join-forces-enhanced-post-marketing-monitoring-covid-19-vaccines-europe."},{"key":"10.1016\/j.gaceta.2021.11.003_bib0110","unstructured":"Estrategia de detecci\u00f3n precoz, vigilancia y control de COVID-19. Actualizado 12 de agosto de 2021. Ministerio de Sanidad, Gobierno de Espa\u00f1a; 2021. (Consultado el 25\/6\/2021.) Disponible en: https:\/\/www.mscbs.gob.es\/profesionales\/saludPublica\/ccayes\/alertasActual\/nCov\/documentos\/COVID19_Estrategia_vigilancia_y_control_e_indicadores.pdf."},{"key":"10.1016\/j.gaceta.2021.11.003_bib0115","article-title":"Efectividad de la primera dosis de vacuna BNT162b2 para prevenir la COVID-19 en personal sanitario","volume":"95","author":"Gras-Valent\u00ed","year":"2021","journal-title":"Rev Esp Salud P\u00fablica."},{"key":"10.1016\/j.gaceta.2021.11.003_bib0120","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/S0140-6736(21)00790-X","article-title":"COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study","volume":"397","author":"Hall","year":"2021","journal-title":"Lancet."},{"key":"10.1016\/j.gaceta.2021.11.003_bib0125","doi-asserted-by":"crossref","first-page":"753","DOI":"10.15585\/mmwr.mm7020e2","article-title":"Interim estimates of vaccine effectiveness of Pfizer-BioNTech and Moderna COVID-19 vaccines among health care personnel - 33 U.S. Sites January-March 2021","volume":"70","author":"Pilishvili","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.gaceta.2021.11.003_bib0130","article-title":"Effectiveness of the Comirnaty (BNT162b2, BioNTech\/Pfizer) vaccine in preventing SARS-CoV-2 infection among healthcare workers, Treviso province, Veneto region","volume":"26","author":"Fabiani","year":"2021","journal-title":"Italy, 27 December 2020 to 24 March 2021. Euro Surveill."},{"key":"10.1016\/j.gaceta.2021.11.003_bib0135","first-page":"2100452","article-title":"Effectiveness of mRNA COVID-19 vaccines in preventing SARS-CoV-2 infections and COVID-19 hospitalisations and deaths in elderly long-term care facility residents","volume":"26","author":"Mazagatos","year":"2021","journal-title":"Spain, weeks 53 2020 to 13 2021. Euro Surveill"},{"key":"10.1016\/j.gaceta.2021.11.003_bib0140","doi-asserted-by":"crossref","unstructured":"Mart\u00ednez-Baz I, Miqueleiz A, Casado I, et al. Effectiveness of COVID-19 vaccines in preventing SARS-CoV-2 infection and hospitalisation, Navarre, Spain, January to April 2021. Euro Surveill. 202;26:2100438.","DOI":"10.2807\/1560-7917.ES.2021.26.21.2100438"},{"key":"10.1016\/j.gaceta.2021.11.003_bib0145","unstructured":"World Health Organization. Evaluation of COVID-19 vaccine effectiveness. Interim Guidance. WHO: Geneva, Switzerland; 2021. (Consultado el 18\/8\/2021.) Disponible en: https:\/\/www.who.int\/publications\/i\/item\/WHO-2019-nCoV-vaccine_effectiveness-measurement-2021.1."},{"key":"10.1016\/j.gaceta.2021.11.003_bib0150","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.1016\/j.vaccine.2013.04.026","article-title":"The case test-negative design for studies of the effectiveness of influenza vaccine","volume":"31","author":"Foppa","year":"2013","journal-title":"Vaccine."}],"container-title":["Gaceta Sanitaria"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213911121003174?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213911121003174?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T13:23:23Z","timestamp":1759325003000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0213911121003174"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S0213911121003174"],"URL":"https:\/\/doi.org\/10.1016\/j.gaceta.2021.11.003","relation":{},"ISSN":["0213-9111"],"issn-type":[{"value":"0213-9111","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efectividad de la vacuna BNT162b2 para prevenir la COVID-19 en personal sanitario","name":"articletitle","label":"Article Title"},{"value":"Gaceta Sanitaria","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gaceta.2021.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 SESPAS. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}